Observed Side Effects (From Clinical Trials) In the Lancet 2021 Phase 2 trial (n=706), at the highest 4.5 mg/week dose, 88% of participants reported at least one side effect and 63% reported a GI-specific event
[16] [18] Animal studies have not demonstrated teratogenicity, but high doses in pregnancy may theoretically increase the risk of fetal oxalate nephropathy or other metabolic disturbances
injections: How they compare Semaglutide is an active ingredient in some medicines called GLP-1 receptor agonists (GLP-1 RAs)
In the peptide therapy context, AbbVie's Lupron (leuprolide) franchise treating prostate cancer, endometriosis, uterine fibroids, and precocious puberty via GnRH agonism remains a stable legacy contributor, while Botox Therapeutic ($748 million in Q1 2024 alone) constitutes a significant peptide-adjacent revenue stream
17 Extended Content: In the early stages of chemical synthesis of L-carnitine, DL-racemic mixtures were directly synthesized as raw materials, and various resolving agents were used to isolate the L-isomer